MedPath

Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia

Not Applicable
Completed
Conditions
Lower Extremity Problem
Gynecologic Disease
Urinary Tract Disease
Interventions
Registration Number
NCT05574257
Lead Sponsor
Wonkwang University Hospital
Brief Summary

After dividing the patients into two groups, sedation is performed with propofol and remimazolam, respectively, after spinal anesthesia. Compare the patient's body temperature change after surgery.

Detailed Description

Patients in the study were randomly assigned to the propofol group (Group P) and the remimazolam group (Group R) in a 1:1 ratio. Study drugs are prepared in the same 50 ml syringe, double-blind to group assignment. All patients are not given pre-anesthetic medication, and body temperature, blood pressure, and heart rate are measured in the recovery room after surgery at 10-minute intervals from just before anesthesia induction to surgery. If hypotension or bradycardia occurs during surgery and is not corrected even after rapid fluid infusion, ephedrine is increased by 10 mg or glycopyrrolate 0.2 mg or atropine 0.5 mg is administered.

If spinal anesthesia is successfully performed, check the patient's anesthesia height. When the appropriate level of anesthesia is confirmed, Group P receives propofol at 25-100ug/kg/min and maintains the BIS at 70-80. Group R receives remimazolam at 1-20ug/kg/min and maintains BIS between 70-80. Both groups apply a conventionally used air heating device, and the operating room temperature is kept at 20 °C. If shivering occurs during surgery, the elapsed time from induction and the shivering grades are recorded.

At the end of the surgery, record total anesthesia time and surgery time, fluid dose, and drug use. After moving to the recovery room, the patient's body temperature, systolic blood pressure, diastolic pressure, heart rate, the incidence of shivering, and the grade of shivering are checked. When shivering occurs, a forced air-warming device is applied first, and if shivering continues, administer meperidine in 5mg increments until the patient is comfortable and record the total dose.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Those aged between 19 and under 65 who are undergoing surgery under spinal anesthesia at Wonkwang University Hospital.
  • American Society of Anesthesiologists' physical status class (ASA) award class I-III.
Exclusion Criteria
  • Patients with fever before surgery
  • Patients taking antipyretics before surgery
  • Patients who are chronically using anti-inflammatory drugs
  • High-risk patients with ASA class IV or higher
  • Patient who refused sedation
  • Patients with thyroid dysfunction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group PPropofolThe group received propofol injection at 25-100ug/kg/min (immediately after spinal anesthesia to the end of surgery).
Group RRemimazolamThe group received remimazolam injection at 1-20ug/kg/min (immediately after spinal anesthesia to the end of surgery).
Primary Outcome Measures
NameTimeMethod
The incidence of perioperartive hypothermiaAt PACU (Post Anesthesia Care Unit)

measure the body temperature three times on the tympanic membrane and enter the highest value.

Secondary Outcome Measures
NameTimeMethod
core body temperatureAt PACU

Every 10 minutes, measure the body temperature three times on the tympanic membrane and enter the highest value.

shivering gradesAt PACU

1. None (Grade 0): no shivering noted on palpation of the masseter, neck, or chest wall

2. Mild (Grade 1): shivering localized to the neck and/or thorax only

3. Moderate (Grade 2): shivering involved the gross movement of the upper extremities (in addition to neck and thorax)

4. Severe (Grade 3): shivering involved gross trunk and upper and lower extremities movements.

Trial Locations

Locations (1)

Wonkwag UH

🇰🇷

Iksan, Jeollabukdo, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath